Application

15613560 · Tetrahydro-Pyrido-Pyrimidine Derivatives

Filed 2017-06-05 · Abandoned The official file ↗ · Art unit 1624 · Examiner Susanna Moore Typical · CPC C07D 471/04 · Novartis AG · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.4 mo

to disposition 17.7 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.